Biotransformation and Metabolite Elucidation of Xenobiotics - Characterization and Identification (Electronic book text, 1st edition)


The goal of this book is to improve the readers' knowledge of metabolite elucidation in drug metabolism by exposing them to in depth coverage of the biotransformation of xenobiotics, strategies for identifying and characterizing metabolites, FDA guidelines, and case studies on how to improve the decision-making process in structural modification of drug candidates to reduce toxicity.

The book consists of 8 chapters; it first provides an introduction on biotransformation of xenobiotics, and then presents modern approaches and strategies for dealing with metabolite characterization, using tools such as LC-MS, H-D exchange, stable isotopes LC-MS-NMR, and radiolabeled compounds. Also, strategies for dealing with reactive intermediates in drug discovery and development are presented as well as case studies on improving the decision-making process in the structural modification of drug candidates. The last chapter discusses the regulatory perspectives of safety testing of drug metabolites and why, how, and when to test their safety.


Delivery AdviceNot available

Toggle WishListAdd to wish list
Review this Item

Product Description

The goal of this book is to improve the readers' knowledge of metabolite elucidation in drug metabolism by exposing them to in depth coverage of the biotransformation of xenobiotics, strategies for identifying and characterizing metabolites, FDA guidelines, and case studies on how to improve the decision-making process in structural modification of drug candidates to reduce toxicity.

The book consists of 8 chapters; it first provides an introduction on biotransformation of xenobiotics, and then presents modern approaches and strategies for dealing with metabolite characterization, using tools such as LC-MS, H-D exchange, stable isotopes LC-MS-NMR, and radiolabeled compounds. Also, strategies for dealing with reactive intermediates in drug discovery and development are presented as well as case studies on improving the decision-making process in the structural modification of drug candidates. The last chapter discusses the regulatory perspectives of safety testing of drug metabolites and why, how, and when to test their safety.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

John Wiley & Sons

Country of origin

United States

Release date

June 2011

Availability

We don't currently have any sources for this product. If you add this item to your wish list we will let you know when it becomes available.

First published

2011

Editors

Format

Electronic book text

Pages

328

Edition

1st edition

ISBN-13

978-1-118-12617-2

Barcode

9781118126172

Categories

LSN

1-118-12617-3



Trending On Loot